- Home
- FCNCO vs CADL Comparison
FCNCO vs CADL Comparison
Compare FCNCO & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FCNCO | CADL |
|---|---|---|
| Founded | 1898 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 339.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | FCNCO | CADL |
|---|---|---|
| Price | $21.46 | $5.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $19.43 |
| AVG Volume (30 Days) | 23.8K | ★ 881.0K |
| Earning Date | 10-23-2025 | 11-13-2025 |
| Dividend Yield | ★ 6.17% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 169.27 | N/A |
| Revenue | ★ $8,897,000,000.00 | N/A |
| Revenue This Year | $0.56 | N/A |
| Revenue Next Year | $2.24 | N/A |
| P/E Ratio | $9.80 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $20.57 | $4.25 |
| 52 Week High | $24.40 | $13.68 |
Technical Indicators
Market Signals| Indicator | FCNCO | CADL |
|---|---|---|
| Relative Strength Index (RSI) | 50.82 | 53.29 |
| Support Level | $20.89 | $5.22 |
| Resistance Level | $21.63 | $5.78 |
| Average True Range (ATR) | 0.20 | 0.31 |
| MACD | 0.08 | -0.06 |
| Stochastic Oscillator | 91.89 | 51.84 |
Price Performance
Historical ComparisonAbout FCNCO First Citizens BancShares Inc. 5.625% Non-Cumulative Perpetual Preferred Stock Series C
First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through our extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.